Sugi Predict

Sugi Predict / Compounds / SCHEMBL1056558

SCHEMBL1056558

SCHEMBL1056558

CC(C)Oc1noc(C2CC(c3ccc(OC(F)(F)F)cc3)CN(C(=O)N3CC[S+]([O-])CC3)C2)n1

nearest known ligand 0.57

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ F2R P25116 5/20 0.57
▸ CNR1 P21554 1/20 0.57
▸ TMEM97 Q5BJF2 1/20 0.57
▸ DPP4 P27487 3/20 0.37
▸ DPP7 Q9UHL4 1/20 0.37
▸ SCD5 Q86SK9 1/20 0.34
▸ TRPA1 O75762 2/20 0.33
▸ HRH3 Q9Y5N1 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ GRM5 P41594 4/20 0.32
▸ EPHX2 P34913 2/20 0.32
▸ DPP8 Q6V1X1 1/20 0.32
▸ DPP9 Q86TI2 1/20 0.32
▸ FAAH O00519 1/20 0.31
▸ MGLL Q99685 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1056313 0.90 F2R (0.58) F2RCNR1TMEM97DPP4DPP7
SCHEMBL1056158 0.89 F2R (0.59) F2RCNR1TMEM97DPP4DPP7
SCHEMBL1055662 0.88 F2R (0.74) F2RCNR1TMEM97DPP4DPP7
SCHEMBL1055659 0.88 F2R (0.64) F2RCNR1TMEM97DPP4DPP7
SCHEMBL1051463 0.88 F2R (0.56) F2RCNR1TMEM97DPP4DPP7
SCHEMBL3760964 0.85 F2R (0.77) F2RCNR1TMEM97DPP4DPP7
SCHEMBL3765603 0.83 F2R (0.56) F2RCNR1TMEM97DPP4DPP7
SCHEMBL3760759 0.83 F2R (0.58) F2RCNR1TMEM97DPP4DPP7
SCHEMBL1054200 0.82 F2R (0.46) F2RCNR1TMEM97TRPA1MEN1
SCHEMBL1053729 0.80 F2R (0.46) F2RCNR1TMEM97KMT2AEPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120220563-A1 Substituted piperidines BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2012-08-30 — — US disclosed
US-20120220563-A1 Substituted piperidines BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2012-08-30 — — US disclosed
US-8084469-B2 Substituted piperidines BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2011-12-27 — — US disclosed
US-8084469-B2 Substituted piperidines BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2011-12-27 — — US disclosed
US-8084469-B2 Substituted piperidines BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2011-12-27 — — US disclosed
US-20110021489-A1 SUBSTITUTED PIPERIDINES BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2011-01-27 — — US disclosed
US-20110021489-A1 SUBSTITUTED PIPERIDINES BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2011-01-27 — — US disclosed
US-20110021489-A1 SUBSTITUTED PIPERIDINES BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2011-01-27 — — US disclosed
WO-2010136144-A1 SUBSTITUTED PIPERIDINES BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-12-02 — — WO disclosed
WO-2010136144-A1 SUBSTITUTED PIPERIDINES BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-12-02 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110021489-A1 SUBSTITUTED PIPERIDINES VHL, PIR, PIGO F2R 1339/4885CNR1 460/4885TMEM97 903/4885
US-20120220563-A1 Substituted piperidines VHL, PIR, PIGO F2R 1339/4885CNR1 460/4885TMEM97 903/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.